Impaired coronary flow and left ventricular dysfunction after mechanical recanalization in acute myocardial infarction: Role of neurohumoral activation?

Basic Research in Cardiology

Volumn 97, Issue 5, 2002, Pages 399-408

  Schäfer, Ulrich ^a   Kurz, Thomas ^a   Jain, Deepak ^a   Hartmann, Franz ^a   Dendorfer, Andreas ^b   Tölg, Ralph ^a   Raasch, Walter ^b   Dominiak, Peter ^b   Katus, Hugo ^a   Richardt, Gert ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Angioplasty; Myocardial infarction; Neurohormones; Reperfusion; Vasoconstriction

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ARGIPRESSIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CREATINE KINASE; CREATINE KINASE MB; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENDOTHELIN 1; LACTATE DEHYDROGENASE; NORADRENALIN; TROPONIN T; VASOPRESSIN;

ACUTE HEART INFARCTION; ADULT; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; BIOCHEMISTRY; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY OBSTRUCTION; CORONARY ARTERY RECANALIZATION; CORRELATION ANALYSIS; DISEASE ASSOCIATION; ELECTIVE SURGERY; ENZYME BLOOD LEVEL; ENZYME RELEASE; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE REPERFUSION; HEART MUSCLE REVASCULARIZATION; HEMODYNAMICS; HORMONAL REGULATION; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HORMONE RELEASE; HUMAN; MALE; METABOLIC ACTIVATION; NEUROENDOCRINE SYSTEM; PROTEIN BLOOD LEVEL; PULMONARY ARTERY; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGED; ANGINA PECTORIS; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANGIOTENSIN II; BIOLOGICAL MARKERS; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NEUROTRANSMITTER AGENTS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0036732840     PISSN: 03008428     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003950200049     Document Type: Article

References (56)

1. The many aspects of endothelins in ischemia-reperfusion injury: Emergence of a key mediator
2. Mechanism of "myocardial stunning"
3. Oxygen derived free radicals and myocardial reperfusion injury: An overview
4. Myocardial "stunning" in man
5. ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: Executive summary and recommendations. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the Management of Patients with Unstable Angina)
6. Arginine vasopressin V1-receptor antagonism in an ovine model of acute myocardial infarction
7. Coronary flow reserve during coronary angioplasty in patients with recent myocardial infarction: Relationship to stenosis and myocardial viability
8. Plasma corticotrophin releasing hormone, vasopressin, ACTH and cortisol responses to acute myocardial infarction
9. Attenuation of myocardial stunning by the AT1 receptor antagonist candesartan
10. Pharmacological modulation of myocardial stunning
11. Attenuation of myocardial stunning by the ACE inhibitor ramiprilat through a signal cascade of bradykinin and prostaglandins but not nitric oxide
12. Determination of catecholamines in rat heart tissue and plasma samples by liquid chromatography with electrochemical detection
13. Interaction between coronary occlusion and the renin-angiotensin system in the dog
14. Unstable angina with fatal outcome: Dynamic coronary thrombosis leading to infarction and/or sudden death
15. Role of endothelium in responses of vascular smooth muscle
16. Coronary vasospasm in humans: The role of atherosclerosis and of impaired endothelial vasodilator function
17. TIMI frame count. A quantitative method of assessing coronary artery flow
18. Relationship between TIMI frame count and clinical outcomes after thrombolytic administration
19. Hemodynamic effects of infused arginine vasopressin in congestive heart failure
20. α-Adrenergic blockade improves recovery of myocardial perfusion and function after coronary stenting in patients with acute myocardial infarction
21. Low frequency spectral component of heart rate variability and myocardial beta-adrenoceptor density after acute myocardial infarction
22. Endothelin and myocardial inschemia
23. α-Adrenergic coronary vasoconstriction and myocardial ischemia in humans
24. Cardiac sympathetic nerve activity and progressive vasoconstriction distal to coronary stenosis: Feed-back aggravation of myocardial ischemia
25. Perfusion-contraction match and mismatch
26. Evidence for a vasopressin system in the rat heart
27. Myocardial perfusion patterns related to thrombolysis in myocardial infarction perfusion grades after coronary angioplasty in patients with acute anterior wall myocardial infarction
28. AT1 receptor blockade in experimental myocardial ischemia/reperfusion
29. 2-adrenergic constriction in the canine epicardial coronary microcirculation
30. Cardiac endothelin release and infarct size, myocardial blood flow, and ventricular function in canine infarction and reperfusion
31. Potential benefits of late reperfusion of infarcted myocardium. The open artery hypothesis
32. Local and neurohumoral control of coronary blood flow
33. Endothelins
34. 125I-labeled endothelin-1 binding in rat cardiac membranes
35. A sympathetic reflex elicited by experimental coronary occlusion
36. Coronary vasoconstriction induced by vasopressin. Production of myocardial ischemia in dogs by constriction of nondiseased small vessels
37. Coronary artery disease-free radical damage, antioxidant protection and the role of homocysteine
38. A randomized placebo-controlled trial of combined early intravenous captopril and recombinant tissue-type plasminogen activator therapy in acute myocardial infarction
39. Plasma kinins increase after angiotensin-converting enzyme inhibition in human subjects
40. Endothelin in myocardial reperfusion
41. Angiotensin converting enzyme inhibitors
42. Limitation of coronary reserve after successful angioplasty is prevented by oral pretreatment with alpha1-adrenergic antagonist
43. Myocardial perfusion-contraction matching. Implications for coronary heart disease and hibernation
44. Prediction of short- and intermediate-term prognosis of patients with acute myocardial infarction using myocardial contrast echocardiography one day after recanalization
45. Altered effects of vasopressin on the coronary circulation after ischemia
46. Advantages and applications of the centerline method for characterizing regional ventricular function
47. Inhibition of adrenergic vasoconstriction by endothelial shear stress
48. 1-adrenergic constriction
49. Beneficial effects of bradykinin on porcine ischemic myocardium
50. Chronic myocardial hibernation in humans. From bedside to bench
51. Reperfusion enhances the local release of endothelin after regional myocardial ischemia
52. Ventricular receptors stimulate vasopressin release during hemorrhage
53. Comparison of the effects of angiotensin converting enzyme inhibition with those of angiotensin II receptor antagonism on functional and metabolic recovery in the post-ischemic working rat heart as studied by 31P nuclear magnetic resonance
54. Approaches to the prevention of coronary vascular dysfunction caused by myocardial ischemia and reperfusion
55. Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction
56. Endothelin-1 enhances neutrophil adhesion to human coronary artery endothelial cells: Role of ET(A) receptors and platelet-activating factor